Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Subtilisin-like serine protease C (CspC) is the primary molecular receptor responsible for initiating the germination of Clostridioides difficile spores in response to host signals. Although it belongs to the subtilisin-like protease family, CspC is a pseudoprotease that lacks catalytic activity and has evolved to function as a specialized receptor for bile acids, such as taurocholate, within the mammalian gut (Francis et al., 2013, Nature). Upon binding to germinants, CspC triggers a signaling cascade that activates the protease CspB, which subsequently processes the cortex-lytic enzyme SleC to allow for spore outgrowth and the transition to toxin-producing vegetative cells (Bhattacharjee et al., 2016, Scientific Reports). Because C. difficile spores are highly resistant to antibiotics and are the primary cause of disease recurrence, CspC represents a critical therapeutic target for preventing the onset of infection. Current drug development efforts focus on small molecule inhibitors and bile acid analogs that can block CspC to maintain spores in a dormant, non-pathogenic state (Kochan et al., 2017, PLOS Pathogens).
Inhibition of the bile acid-induced germination signaling pathway by acting as a competitive or non-competitive antagonist at the CspC receptor site.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Subtilisin-like serine protease C (CspC) (CspC).